← SynDRA
S-111
SynDRA canonical compound SYN1959534 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | PARP1 | SLC6A2 | SLC6A4 |
| Mechanism of action | PARP inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- PARP1 inhibitor (cancer), Sentinel Oncology
Look up S-111 in the interactive SynDRA portal →